United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 373.785 USD 3.43% Market Closed
Market Cap: 16.6B USD
Have any thoughts about
United Therapeutics Corp?
Write Note

United Therapeutics Corp
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

United Therapeutics Corp
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
United Therapeutics Corp
NASDAQ:UTHR
PP&E Net
$1.1B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbvie Inc
NYSE:ABBV
PP&E Net
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.3B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
14%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6.1B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$1.8B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
9%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.3B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
20%

See Also

What is United Therapeutics Corp's PP&E Net?
PP&E Net
1.1B USD

Based on the financial report for Jun 30, 2024, United Therapeutics Corp's PP&E Net amounts to 1.1B USD.

What is United Therapeutics Corp's PP&E Net growth rate?
PP&E Net CAGR 10Y
9%

Over the last year, the PP&E Net growth was 17%. The average annual PP&E Net growth rates for United Therapeutics Corp have been 15% over the past three years , 9% over the past five years , and 9% over the past ten years .

Back to Top